Drug Detail

Information about CP-751,871 + RAD001

Generic Name
CP-751,871 + RAD001
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery
Approval Status
Discontinued?
Indications
Overall Strategy
Oncogenic Signal Path Based
Strategy
Block related tumor signal paths
Drug Category
IGF1R inhibitor + mTOR Inhibitor


Links


Trials of this drug

  

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
   

Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed